Maria P. Molina-Guerrero

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Epilepsia partialis continua as an isolated manifestation of anti-NMDA receptor encephalitis: a case report.

Epilepsia partialis continua as an isolated manifestation of anti-NMDA receptor encephalitis: a case report.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: April 02, 2025

Reply: assessing the effect of oral glutamine on the MELAS phenotype requires appropriate study designs.

Reply: assessing the effect of oral glutamine on the MELAS phenotype requires appropriate study designs.

Journal: Neuroradiology

Published: January 15, 2024

Magnetic resonance spectroscopy in MELAS syndrome: correlation with CSF and plasma metabolite levels and change after glutamine supplementation.

Magnetic resonance spectroscopy in MELAS syndrome: correlation with CSF and plasma metabolite levels and change after glutamine supplementation.

Journal: Neuroradiology

Published: July 12, 2023

Delayed Diagnosis of Congenital Myasthenic Syndromes Erroneously Interpreted as Mitochondrial Myopathies.

Delayed Diagnosis of Congenital Myasthenic Syndromes Erroneously Interpreted as Mitochondrial Myopathies.

Journal: Journal of clinical medicine

Published: March 11, 2023

Serum GDF-15 Levels Accurately Differentiate Patients with Primary Mitochondrial Myopathy, Manifesting with Exercise Intolerance and Fatigue, from Patients with Chronic Fatigue Syndrome.

Serum GDF-15 Levels Accurately Differentiate Patients with Primary Mitochondrial Myopathy, Manifesting with Exercise Intolerance and Fatigue, from Patients with Chronic Fatigue Syndrome.

Journal: Journal of clinical medicine

Published: February 15, 2023

Reply: High-dose oral glutamine can reduce cerebrospinal fluid glutamate in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes without a beneficial clinical or cerebral tissue effect.

Reply: High-dose oral glutamine can reduce cerebrospinal fluid glutamate in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes without a beneficial clinical or cerebral tissue effect.

Journal: European journal of neurology

Published: December 16, 2022

New Cerebellar Ataxia, Neuropathy, Vestibular Areflexia Syndrome cases are caused by the presence of a nonsense variant in compound heterozygosity with the pathogenic repeat expansion in the RFC1 gene.

New Cerebellar Ataxia, Neuropathy, Vestibular Areflexia Syndrome cases are caused by the presence of a nonsense variant in compound heterozygosity with the pathogenic repeat expansion in the RFC1 gene.

Journal: Clinical genetics

Published: July 26, 2022

High-dose oral glutamine supplementation reduces elevated glutamate levels in cerebrospinal fluid in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome.

High-dose oral glutamine supplementation reduces elevated glutamate levels in cerebrospinal fluid in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome.

Journal: European journal of neurology

Published: April 25, 2022

Elevated glutamate and decreased glutamine levels in the cerebrospinal fluid of patients with MELAS syndrome.

Elevated glutamate and decreased glutamine levels in the cerebrospinal fluid of patients with MELAS syndrome.

Journal: Journal of neurology

Published: November 02, 2021

Antisaccades and memory-guided saccades in genetic generalized epilepsy and temporal lobe epilepsy.

Antisaccades and memory-guided saccades in genetic generalized epilepsy and temporal lobe epilepsy.

Journal: Epilepsy & behavior : E&B

Published: June 14, 2021

Corrigendum to "Peripapillary retinal nerve fibre layer thinning in genetic generalized epilepsy" [Seizure: European Journal of Epilepsy 71 (2019) 201-206].

Corrigendum to "Peripapillary retinal nerve fibre layer thinning in genetic generalized epilepsy" [Seizure: European Journal of Epilepsy 71 (2019) 201-206].

Journal: Seizure

Published: March 02, 2021

Cerebral amyloid angiopathy-related inflammation: clinical features and treatment response in a case series.

Cerebral amyloid angiopathy-related inflammation: clinical features and treatment response in a case series.

Journal: Neurologia

Published: October 28, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026